CLYD
CLYDCIK 0002094256
No XBRL size data yet — common for recent IPOs and new registrants (SEC companyfacts lag), foreign filers reporting in non-USD, or non-standard filers.
Every 8-K is open in full. Other 10-Ks and 10-Qs show a 3-bullet preview. A free account reads 3 more full reports a month. Generating a report requires a verified account.
Sign up freeWant to see a complete report first? Today's free report (VC 10-Q) is open in full — no account needed.
Summary not yet generated.
Summary not yet generated.
Partner
Trade CLYD commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Summary not yet generated.
Summary not yet generated.
Latest financial statements
From 10-Q filed Jul 14, 2026 (period ending Jun 30, 2026). As printed on the EDGAR/iXBRL face — not generated by the model.
Consolidated Statement of Operations (Unaudited)
| Description | Three months ended June 30, 2026 | Six months ended June 30, 2026 |
|---|---|---|
| Revenues | — | — |
| Operating expense | — | — |
| Earnings before income taxes | — | — |
| Provision for income taxes | — | — |
| Net income | — | — |
| Earnings per share of common stock basic and diluted | — | — |
| Weighted average number of shares of common stock outstanding basic and diluted | 100 | 100 |
Consolidated Balance Sheets
| Description | At June 30, 2026 (Unaudited) | At December 31, 2025 |
|---|---|---|
| ASSETS | ||
| Current assets | — | — |
| Other assets | — | — |
| Total Assets | — | — |
| LIABILITIES AND EQUITY | ||
| Current liabilities | — | — |
| Other liabilities | — | — |
| Commitments and contingencies | ||
| Equity: | ||
| Common Stock, par value $0.0001 per share; 100 shares authorized as of June 30, 2026 and December 31, 2025; 100 shares issued and outstanding as of June 30, 2026 and December 31, 2025 | 0 | 0 |
| Additional paid-in capital | — | — |
| Due from shareholder | (0) | (0) |
| Retained earnings | — | — |
| Accumulated other comprehensive loss | — | — |
| Total Equity | — | — |
| Total Liabilities and Equity | — | — |
Consolidated Statement of Cash Flows (Unaudited)
| Description | Six months ended June 30, 2026 |
|---|---|
| Operating Activities | |
| Net income | — |
| Adjustments to reconcile net income to net cash flow provided by operating activities: | |
| Change in assets and liabilities | — |
| Net cash flow provided by operating activities | — |
| Investing Activities | |
| Net cash flow provided by investing activities | — |
| Financing Activities | |
| Net cash flow provided by financing activities | — |
| Net increase in cash and cash equivalents | — |
| Cash and cash equivalents at beginning of year | — |
| Cash and cash equivalents at end of the period | — |
Amounts as printed on the EDGAR/iXBRL face. Labels, columns, and figures are the filing face, not a GAAP stencil. Interactive statements & notes on EDGAR ↗